Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects

• Kentaro Oniki,

  Affiliation Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan

  ⨯
• Junji Saruwatari ,

  * E-mail: junsaru@gpo.kumamoto-u.ac.jp

  Affiliation Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan

  ⨯
• Tomoko Izuka,

  Affiliation Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan

  ⨯
• Ayami Kajiwara,

  Affiliation Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan

  ⨯
• Kazunori Morita,

  Affiliation Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan

  ⨯
• Misaki Sakata,

  Affiliation Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan

  ⨯
• Koji Otake,

  Affiliation Japanese Red Cross Kumamoto Health Care Center, Kumamoto, Japan

  ⨯
• Yasuhiro Ogata,

  Affiliation Japanese Red Cross Kumamoto Health Care Center, Kumamoto, Japan

  ⨯
• Kazuko Nakagawa

  Affiliations Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan, Center for Clinical Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan

  ⨯